New Fat-Targeting drug tested in healthy volunteers
NCT ID NCT05234736
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a single injection of CBL-514 in 10 healthy volunteers to see how the body processes it and whether it is safe. Researchers measured drug levels in the blood and monitored for side effects. The goal was to gather basic safety and drug behavior information, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CBL-514 injection
What this could lead to
If successful, this study will help determine the right dose and safety of CBL-514 for future trials targeting fat reduction.
What could go wrong
This is a small, early-phase study in healthy people, not patients. It only looks at drug levels and safety, not effectiveness for any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBCUTANEOUS FAT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
DermResearch Inc
Austin, Texas, 78759, United States